BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/18/2025 7:43:29 AM | Browse: 2 | Download: 0
| Category |
Surgery |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Right patient approach to experimental stromal cell therapies for gastrointestinal tumors
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Francesca Vescio, Silvia Curcio, Isabella Aquila, Michele Ammendola and Alessandro Pasquale Tarallo |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Michele Ammendola, MD, Department of Experimental and Clinical Medicine, Digestive Surgery Unit, University "Magna Graecia" Medical School, University Hospital "R. Dulbecco", Viale Europa, Catanzaro 88100, Italy. michele.ammendola@libero.it |
| Key Words |
Experimental therapies; Surgery; Non-standardized treatment; Gastrointestinal tumor; Informed consent |
| Core Tip |
Experimental therapies targeting immune stromal cells in the treatment of gastrointestinal tumors pose surgical and medico-legal challenges. These treatments, being innovative, require that the patient's informed consent represent a truly relational and cognitive process, based on understanding and free choice. It is essential that the patient be able to understand the experimental nature of the therapy, the potential benefits and risks, as well as the implications for their health and personal dignity. Furthermore, if the patient participates in a non-standardized treatment, they must be aware that the outcomes, positive or negative, are not yet known with certainty. |
| Citation |
Vescio F, Curcio S, Aquila I, Ammendola M, Tarallo AP. Right patient approach to experimental stromal cell therapies for gastrointestinal tumors. World J Gastrointest Oncol 2025; In press |
 |
Received |
|
2025-08-06 14:51 |
 |
Peer-Review Started |
|
2025-08-06 14:52 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-08-17 07:53 |
 |
Revised |
|
2025-08-30 18:16 |
 |
Second Decision |
|
2025-11-18 01:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-11-18 07:43 |
 |
Articles in Press |
|
2025-11-18 07:43 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345